What is the role of interleukin 33 and ST2 receptor in myasthenia gravis?

J Neuroimmunol. 2018 Feb 15:315:50-57. doi: 10.1016/j.jneuroim.2017.12.015. Epub 2017 Dec 20.

Authors

Izabela Monika Rozmilowska¹, Monika Helena Adamczyk-Sowa²

Affiliations

¹ Department of Neurology in Zabrze, Medical University of Silesia, ul. 3-go Maja 13-15, Zabrze 41-800, Poland. Electronic address: izabela.rozmilowska@med.sum.edu.pl.
² Department of Neurology in Zabrze, Medical University of Silesia, ul. 3-go Maja 13-15, Zabrze 41-800, Poland.

PMID: 29306406
DOI: 10.1016/j.jneuroim.2017.12.015

No abstract available

MeSH terms

Adult
Aged
Female
Humans
Interleukin-1 Receptor-Like 1 Protein / blood*
Interleukin-33 / blood*
Male
Middle Aged
Myasthenia Gravis / blood*

Substances

IL1RL1 protein, human
IL33 protein, human
Interleukin-1 Receptor-Like 1 Protein
Interleukin-33